BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19709803)

  • 1. An epitome of DNA repair related genes and mechanisms in thyroid carcinoma.
    Gatzidou E; Michailidi C; Tseleni-Balafouta S; Theocharis S
    Cancer Lett; 2010 Apr; 290(2):139-47. PubMed ID: 19709803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic background of carcinogenesis in the thyroid gland.
    Lewiński A; Wojciechowska K
    Neuro Endocrinol Lett; 2007 Apr; 28(2):77-105. PubMed ID: 17435680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic dysregulation in thyroid neoplasia.
    Kondo T; Asa SL; Ezzat S
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):389-400, ix. PubMed ID: 18502333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations and DNA repair in human carcinogenesis.
    Dixon K; Kopras E
    Semin Cancer Biol; 2004 Dec; 14(6):441-8. PubMed ID: 15489137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene rearrangements in radiation-induced thyroid carcinogenesis.
    Rabes HM
    Med Pediatr Oncol; 2001 May; 36(5):574-82. PubMed ID: 11340615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome instability and DNA damage accumulation in gene-targeted mice.
    Nordstrand LM; Ringvoll J; Larsen E; Klungland A
    Neuroscience; 2007 Apr; 145(4):1309-17. PubMed ID: 17218062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular genetics of pancreatic ductal carcinoma.
    Sohn TA
    Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations.
    Shahedian B; Shi Y; Zou M; Farid NR
    Mol Genet Metab; 2001 Feb; 72(2):155-63. PubMed ID: 11161841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis.
    Kiyohara C; Takayama K; Nakanishi Y
    Lung Cancer; 2006 Dec; 54(3):267-83. PubMed ID: 16982113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid tumorigenesis and molecular markers in thyroid cancer.
    Kouniavsky G; Zeiger MA
    Curr Opin Oncol; 2010 Jan; 22(1):23-9. PubMed ID: 19907326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis.
    Iuliano R; Le Pera I; Cristofaro C; Baudi F; Arturi F; Pallante P; Martelli ML; Trapasso F; Chiariotti L; Fusco A
    Oncogene; 2004 Nov; 23(52):8432-8. PubMed ID: 15378013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long duration exposure to cadmium leads to increased cell survival, decreased DNA repair capacity, and genomic instability in mouse testicular Leydig cells.
    Singh KP; Kumari R; Pevey C; Jackson D; DuMond JW
    Cancer Lett; 2009 Jun; 279(1):84-92. PubMed ID: 19232459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of genetic factors in the pathogenesis of thyroid neoplasms].
    Ferenc T; Maciaszczyk K; Gesing A; Lewiński A
    Postepy Hig Med Dosw; 1997; 51(4):367-84. PubMed ID: 9446100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.
    Mitsutake N; Knauf JA; Mitsutake S; Mesa C; Zhang L; Fagin JA
    Cancer Res; 2005 Mar; 65(6):2465-73. PubMed ID: 15781663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular mechanisms of carcinogenesis: the role of systems of DNA repair].
    Moustacchi E
    Bull Acad Natl Med; 1998; 182(1):33-46; discussion 47. PubMed ID: 9622930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.
    Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
    Oncogene; 2005 Feb; 24(8):1455-60. PubMed ID: 15608681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.